ENDRA Life Sciences Management
Management criteria checks 2/4
ENDRA Life Sciences' CEO is Alex Tokman, appointed in Aug 2024, has a tenure of less than a year. directly owns 0.001% of the company’s shares, worth $29.16. The average tenure of the management team and the board of directors is 0.3 years and 9.3 years respectively.
Key information
Alex Tokman
Chief executive officer
US$103.3k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 0.0009% |
| Management average tenure | less than a year |
| Board average tenure | 9.3yrs |
Recent management updates
Recent updates
ENDRA to submit FDA De Novo request for liver disease monitoring system in coming weeks
Sep 29ENDRA Life Sciences receives European patent for TAEUS system
Aug 24Endra Life Sciences Q2 2022 Earnings Preview
Aug 12We're A Little Worried About ENDRA Life Sciences' (NASDAQ:NDRA) Cash Burn Rate
Aug 08
We're Keeping An Eye On ENDRA Life Sciences' (NASDAQ:NDRA) Cash Burn Rate
Nov 18We Think ENDRA Life Sciences (NASDAQ:NDRA) Needs To Drive Business Growth Carefully
Jul 19ENDRA Life Sciences names Irina Pestrikova Principal Financial Officer
Jun 15ENDRA Life Sciences granted 13th U.S. Patent for its TAEUS platform technology
Jan 13ENDRA Life Sciences renews GE Healthcare collaboration agreement
Dec 21Endra Life prices $5M-share offering
Dec 16Endra Life Sciences EPS beats by $0.02
Nov 16CEO
Alex Tokman (62 yo)
less than a year
Tenure
US$103,347
Compensation
Mr. Alexander Y. Tokman, also known as Alex, serves as an Acting CEO and Director at ENDRA Life Sciences Inc. from August, 2024 also its Chairman. He serves as Independent Director at Izotropic Corporation...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Acting CEO & Chairman | less than a year | US$103.35k | 0.00094% $ 29.2 | |
| Chief Technology Officer | 17.8yrs | US$531.98k | 0.0038% $ 117.0 | |
| Co-Founder | no data | no data | no data | |
| CFO & Secretary | less than a year | no data | no data | |
| Human Resources Leader | 7.5yrs | no data | no data | |
| Head of Regulatory & Clinical Affairs | less than a year | no data | no data |
0.3yrs
Average Tenure
57yo
Average Age
Experienced Management: NDRA's management team is not considered experienced ( 0.3 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Acting CEO & Chairman | 16.8yrs | US$103.35k | 0.00094% $ 29.2 | |
| Independent Director | 11.8yrs | US$75.75k | 0.011% $ 344.6 | |
| Independent Director | 9.3yrs | US$73.57k | 0.00038% $ 11.8 | |
| Independent Director | 4.6yrs | US$65.07k | 0.00019% $ 5.9 | |
| Scientific Advisor | 9.3yrs | no data | no data | |
| Scientific Advisor | no data | no data | no data | |
| Scientific Advisor | 4.8yrs | no data | no data |
9.3yrs
Average Tenure
59.5yo
Average Age
Experienced Board: NDRA's board of directors are considered experienced (9.3 years average tenure).